Trials / Unknown
UnknownNCT03569137
Post-Ibrutinib Colitis and Intestinal Microbiota
Identification of Intestinal Microbiota Biomarkers Predictive of Diarrhea in Patients Treated by Ibrutinib.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Nantes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Identify gut microbiome biomarkers associated with colitis in patients treated with targeted therapy in hematology
Conditions
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2019-08-01
- Completion
- 2020-08-01
- First posted
- 2018-06-26
- Last updated
- 2018-06-26
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03569137. Inclusion in this directory is not an endorsement.